Search Results

Keywords: "United Kingdom"

Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact

August 7, 2020

United Kingdom-based GW Pharmaceuticals posted marginal revenue growth in the second quarter over the previous quarter, citing challenges stemming from the COVID-19 pandemic. GW reported revenue of $121.3 million for the quarter ended June 30 – about the same as the previous period. GW’s quarterly net loss rose slightly to $8.8 million. By product, Epidiolex […]

Read More

Cannabis firm Canopy Growth cuts 30 at Ontario headquarters

July 13, 2020

Canopy Growth Corp. laid off another 30 employees as part of its corporate restructuring, the company confirmed to Marijuana Business Daily. The job losses at Canopy’s Smiths Falls, Ontario, headquarters were first reported by local news website The layoffs, which occurred July 8, affected operations staff members and were the result of Canopy Growth’s […]

Read More

Not all WHO cannabis recommendations would loosen international control, UN drug agency says

June 26, 2020

An analysis by a United Nations monitoring body concludes that most of the World Health Organization’s (WHO) cannabis scheduling recommendations would either have little impact on international drug controls or actually tighten requirements. The analysis, conducted by Vienna-based International Narcotics Control Board (INCB), was provided to member states shortly before the start of the first […]

Read More

UK down-schedules Epidyolex to lowest level for controlled drugs

June 24, 2020

The United Kingdom has down-scheduled Epidyolex to the lowest level of control for drugs, greatly easing restrictions on the cannabidiol medicine and reducing administrative processes for companies wanting to supply it. The U.K. said the new provisions – made through the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2020 – came into force […]

Read More

Clever Leaves seeks Nasdaq listing via merger with SAMA

June 3, 2020

Clever Leaves could become the first medical cannabis company with its main operations in Colombia to list on the Nasdaq stock market. The company said that it entered into a nonbinding letter of intent (LOI) to combine its business with Schultze Special Purpose Acquisition Corp. (SAMA). The two parties are aiming to sign a definitive […]

Read More

Investment group buys Sundial medical cannabis subsidiary for CA$105 million

May 18, 2020 · Updated May 5, 2021

A United Kingdom cultivator that is licensed to grow medical marijuana and hemp has been acquired by a group led by a cannabis investment firm. The U.K.’s Bridge Farm Group, which cultivates ornamental plants, flowers and herbs, announced that it was sold by its parent company, Alberta, Canada-based Sundial Growers, to an entity controlled by […]

Read More

England’s medical cannabis market shows little growth as of early 2020

May 14, 2020

England’s medical cannabis market has barely gotten off the ground since launching about 19 months ago, with a two-tier system in which few patients access products through legal channels while most resort to illicit suppliers. Looking ahead, however, some industry insiders are hopeful that recently implemented import rules could boost the number of legal medical cannabis prescriptions […]

Read More

GW Pharma trims loss to $8 million, warns virus could hit sales

May 12, 2020 · Updated August 7, 2020

GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company warned the COVID-19 pandemic could impact sales if fewer patients visit their doctors. Revenue in the quarter ending March 31 reached $120.6 million, up from $91 million and $109.1 million in […]

Read More

Many Europeans stockpiled illicit cannabis as COVID-19 set in, report suggests

May 8, 2020

Regular cannabis users in Europe might have stocked up on illegal products as the COVID-19 pandemic started to sweep over the continent earlier this year, according to a new analysis of darknet transactions. “This is observed to some extent in the data, where an increase in online trade via darknet markets, driven largely by cannabis products, […]

Read More

Brazil approves first medical cannabis product under 2019 regulations

April 23, 2020

Brazil’s health authorities authorized the first medical cannabis product registered under rules created in December 2019, marking an important milestone for the industry in Latin America’s largest economy. The THC-free CBD product, registered to Brazilian pharmaceutical giant Prati-Donaduzzi, obtained “sanitary authorization” this week, according to a notice in the country’s official Gazette. The company declined interview requests […]

Read More